Tobacco smoking increases the risk of goitre and Graves' disease, but the association with thyroid nodularity and hypothyroidism has not been settled. We investigated 4649 subjects from the general population with questionnaires, thyroid ultrasonography and blood tests. The results were analysed in multivariate regression models. Tobacco smoking was associated with an increased prevalence of thyroid multinodularity (odds ratio (OR) 1·9; 95% confidence interval (CI) 1·4-2·5), but not with increased prevalence of solitary thyroid nodules. The tendency was for a stronger association in the area with the most pronounced iodine deficiency (P for interaction=0·08).
Introduction
A higher goitre prevalence and higher thyroid volumes are found among tobacco smokers than among non-smokers in most studies from iodine-deficient areas (Hegedus et al. 1985 , Nygaard et al. 1993 , Georgiadis et al. 1997 , Barrere et al. 2000 , Brix et al. 2000 , Knudsen et al. 2002 , whereas the association is weaker in iodine-sufficient areas. This has lead to the suggestion of a synergistic effect of iodine deficiency and tobacco smoking on the thyroid, which is in line with experimental studies suggesting that the goitrogenic effect of tobacco smoke is due to thiocyanate acting as a competitive inhibitor of iodine uptake and organification in the thyroid (Fukayama et al. 1992) .
Iodine deficiency is regarded as a risk factor for thyroid nodules, though results from epidemiological studies are ambiguous. As smoking is probably mimicking iodine deficiency, increased prevalence of thyroid multinodularity and multinodular toxic goitre among smokers could be anticipated, as has been observed in iodine-deficient areas (Laurberg et al. 1991 ).
In addition, increased incidences of Graves' disease and especially ophthalmopathy have been observed among smokers (Bartalena et al. 1995) . This is probably due to modification of the autoimmune responses among smokers (Bartalena et al. 1995) . Generally, lower levels of serum thyrotrophin (TSH) have been found among smokers in most studies (Bertelsen & Hegedus 1994) , an association that cannot be explained by the increased number of Graves' patients. The lower serum TSH levels could be due to increased evolution of thyroid autonomy caused by iodine depletion of the thyroid by thiocyanate; however, sympathetic nervous stimulation (Melander et al. 1977) , induction of liver enzymes (Hart et al. 1976) , or inhibition of TSH secretion (Bartalena et al. 1995) could also be involved. A recent, Danish case-control study found increased occurrence of hypothyroidism among smokers, but this association is controversial .
We report data from a recent, large, cross-sectional study with registration of thyroid nodules with ultrasonography after validated principles and, furthermore, thyroid function was registered. The association with smoking habits was analysed and the possible synergy between tobacco smoking and iodine deficiency was evaluated.
Subjects and Methods
A cohort of 9274 subjects was randomly selected from the Danish Civil Registration System within certain age groups. The age groups were chosen to represent women before childbearing age (18-22 years), women within childbearing age (25-30 years), premenopausal women after childbearing age (40-45 years), postmenopausal women (60-65 years), and a group of men for gender comparisons in the age spectrum with the expected highest prevalence of thyroid abnormalities (60-65 years). The cohort was sampled in two Danish cities: Aalborg from the western part of Denmark representing moderate iodine deficiency (45 µg iodine/l in spot urine samples), and Copenhagen from the eastern part of Denmark representing mild iodine deficiency (61 µg/l). For the classification of iodine status, individuals taking iodine supplementation (n=1310) were not included. The participation rate was 50·1%, leaving 4649 subjects for the analyses. The cohort has previously been described in detail (Knudsen et al. 2000a) .
Thyroid nodularity was determined by ultrasonography after standardized criteria as previously described (Knudsen et al. 1999a) , and the classification according to thyroid nodularity has been found to be reproducible between observers (Knudsen et al. 1999a) . Thyroid nodules were registered from a diameter of 5 mm but, for the analyses in this paper, only nodules d10 mm in diameter were included to ensure the clinical relevance of the nodules and to reduce misclassification. The structure of thyroid glands was categorized as normal, as multinodular, or as containing a solitary nodule.
Serum TSH, free tri-iodothyronine (T3) and free thyroxine (T4) were analysed with immunoluminometric assays (LUMItest; BRAHMS, Berlin, Germany). The functional sensitivity of the TSH assay was 0·01 mU/l. Participants were divided into three groups according to thyroid function: normal (serum TSH 0·4-3·6 mU/l), hypothyroid (serum TSH>3·6 mU/l) or hyperthyroid (serum TSH<0·4 mU/l). Only thyroid dysfunction according to TSH values was used (subclinical thyroid dysfunction), as the number of participants with overt thyroid dysfunction was too small to allow reliable analyses. The limits for TSH corresponded to the 2·5th and 97·5th percentiles among subjects with no known thyroid disease and normal ultrasonography of the thyroid (Knudsen et al. 2000b) . Thyroid peroxidase (TPO) antibodies were analysed with a radioimmunoassay (DYNOtest; BRAHMS), and autoimmune hypothyroidism was defined as serum TPO antibodies>60 kU/l (manufacturer's cut-off) and serum TSH>3·6 mU/l. No follow-up on abnormal thyroid function tests was performed; participants with biochemical signs of overt thyroid dysfunction were advised to consult their general physician for checking.
Tobacco smoking habits were registered from questionnaires and subsequent interviews with a physician. Participants were asked about present or previous smoking, daily or occasional smoking, amount of tobacco consumed and type of smoking (cigarettes, cheroots, cigars or pipe tobacco). To combine the different types of tobacco, cigarettes were regarded as 1 g tobacco, cheroots 2 g, and cigars 5 g; the participants were stratified according to gram tobacco consumed corresponding to number of cigarettes. Smokers were classified as non-smokers, ex-smokers, moderate smokers (1-19 g/day) and heavy smokers (minimum 20 g/day), or simply as present smokers or non-smokers dependent on the context.
To account for possible confounding of the analyses, alcohol consumption, familial occurrence of thyroid disease and iodine excretion in the four groups were also registered.
Statistics
Data processing was done with the statistical software SPSS, version 10·0, Scandinavian edition (SPSS, Holte, Denmark). To allow for adjustment for possible confounding in the analyses, all dichotomous variables (multinodularity, solitary nodule, hypo-and hyperthyroidism) were analysed in logistic regression analyses, and continuous variables (serum TSH, free T3 and free T4) were analysed in linear models. Serum TSH was analysed after logarithmic transformation and transformed back before presentation, as the distribution was skewed towards higher values, but normally distributed after transformation.
Age, gender and region of inhabitancy (and thereby iodine status) were included in all regression models, as smoking habits were unevenly distributed between groups and, furthermore, the prevalence of thyroid nodularity as well as thyroid function varied between groups. Familial occurrence of thyroid disease, alcohol consumption and iodine excretion in casual urine samples were tested in all models as confounders, but had no impact on the estimates for the association between tobacco smoking and thyroid disease, and they were not included in the final models. First-order interactions with smoking were tested in all models, but they were not found to be significant. One interaction term has been included in the presentation of data, however, as a trend towards interaction was found between iodine status and smoking in the association with thyroid multinodularity, and this interaction could be important for the interpretation of data.
Tobacco smoking was evaluated as a continuous variable as well as in groups. Only minor differences were found between the continuous variable and a grouped variable and, finally, a variable with four groups was chosen as appropriate regarding the association with thyroid nodularity. On the contrary, four groups were found to be no more informative than two with regard to the association with thyroid function, as small and insignificant differences were found between non-smokers and ex-smokers, and between moderate and heavy smokers.
Results
All participants with known thyroid disease prior to this investigation were excluded from these analyses. The number of subjects eligible for each analysis is summarized in Table 1. A positive association was found between tobacco smoking and the occurrence of multiple nodules in the thyroid at ultrasonography. The observed prevalence of multinodularity was 7·6% among non-smokers and 16·5% among heavy smokers. The difference was slightly less when adjusted for age, gender and iodine status in a multivariate model as reflected by an odds ratio (OR) of 1·9 (95% confidence interval (CI) 1·4-2·5) (Fig. 1) . On the other hand, no association or any trend towards an association was found between tobacco smoking and the occurrence of solitary thyroid nodules (Fig. 1) .
The association between tobacco smoking and thyroid multinodularity seemed different in the two regions with different iodine status, as apparently the association was stronger in the area with the most pronounced iodine deficiency (Fig. 2) . The difference in the association was not statistically significant, however (P for interaction=0·08).
Serum TSH was significantly lower among smokers than among non-smokers and correspondingly higher Table 2 The association between smoking habits and thyroid hormone levels in a Danish population study. Values are means with 95% CI (logarithmic transformation was used for TSH in the analyses) in a linear model correcting for age, sex and iodine status of region of inhabitancy; 4361 participants were eligible for these analyses
The associaiton became statistically insignificant when adjustment for thyroid nodularity and thyroid volume was made. levels of serum free T4 were found among smokers (Table  2 ). These differences disappeared completely if adjustment was made for thyroid volume and thyroid nodularity in the model, suggesting that the differences in TSH and T4 were secondary to -or at least parallel with -changes in thyroid structure. A lower prevalence of subclinical hypothyroidism was found among smokers than among non-smokers. The prevalence of subclinical hypothyroidism was 2·6% (n=41) among smokers and 5·3% (n=147) among non-smokers, and OR was 0·47 (95% CI 0·33-0·67) with adjustment for age, gender and iodine status, when subclinical hypothyroidism was defined as a TSH>3·6 mU/l. With a limit for TSH of 5·0 mU/l, the OR was similar, but with wider confidence intervals (OR 0·55; CI 0·33-0·92). The difference between smokers and non-smokers was similar for autoimmune and non-autoimmune subclinical hypothyroidism; for autoimmune subclinical hypothyroidism, the prevalence was 1·2% among smokers and 2·8% among non-smokers, thus representing approximately half of the cases of hypothyroidism in both groups. No association was found between smoking and subclinical hyperthyroidism, defined as a serum TSH<0·4 mU/l with observed prevalences of 5·3% (n=85) among smokers and 4·7% (n=129) among non-smokers (OR 1·15; CI 0·87-1·53).
Discussion
We report a positive association between smoking habits and the prevalence of thyroid multinodularity at ultrasonography. No previous studies have focused on this association but, in a Swedish study, the increased prevalence of goitre was almost entirely constituted by multinodular glands (Christensen et al. 1984) , and in an Italian study nodular goitre dominated among smokers, but not to the same extent among non-smokers (Lio et al. 1989) . The tendency in our study towards a stronger association in the area with the most pronounced iodine deficiency is in line with findings regarding the association between tobacco smoking and goitre or thyroid enlargement, as this association is stronger in iodine-deficient areas (Knudsen et al. 2002) . This could support the idea that the effect of smoking on the formation of multiple nodules is mediated through thiocyanate, which is a degradation product of cyanide in tobacco smoke, and thiocyanate has been shown to be the major goitrogen from tobacco smoke (Fukayama et al. 1992) . Thus, tobacco smoking may induce intrathyroidal iodine depletion, and iodine deficiency is one of the factors that are thought to facilitate the formation of multinodular glands. However, we found no difference in the occurrence of thyroid multinodularity between our two regions with slightly different iodine intake (Knudsen et al. 2000a) .
Another significant observation was that solitary thyroid nodules showed no association with smoking habits. This was surprising, as some of the solitary nodules may represent early stages of multinodular goitres. On the other hand, it is possible that the occurrence of true adenomas in the thyroid is reduced among smokers, as the incidence of thyroid cancer has been found to be lower among smokers (Galanti et al. 1996 , Kreiger & Parkes 2000 , Rossing et al. 2000 . This could be a parallel with the low incidence of particularly papillary thyroid cancer in iodine-deficient areas. It should be underlined, however, that the solitary nodules in our study most probably entirely represent benign neoplasms. No malignancies have been detected, and the malignancy rate in 'incidentalomas' is generally low (Stark et al. 1983 , Brander et al. 1989 , Knudsen et al. 2000c .
The difference in the associations with tobacco smoking between multiple and solitary nodules supports the idea that the distinction between the two groups is important when investigating aetiology and risk factors. Associations with age, gender and alcohol consumption have also been reported to differ between multiple and solitary thyroid nodules (Knudsen et al. 2000c .
The prevalence of subclinical hypothyroidism was reduced by approximately 50% among smokers compared with non-smokers in our study, and smokers had significantly lower levels of serum TSH. The association between tobacco smoking and hypothyroidism is controversial; previous results are not homogenous as recently reviewed (Vestergaard 2002) .
A Danish study from a moderately iodine-deficient region found a significantly increased occurrence of hypothyroidism among smokers . The discrepancy with our data could in part be caused by the different design of the studies and different selection procedures; the study of Vestergaard et al. (2002) was a case-control study with highly selected patients, as only a part of hypothyroid patients will be referred to hospital care. The self-selection in the control group, where smokers are less prone to participate (Knudsen 2001) , tends to bias towards a positive association between smoking and hypothyroidism. Another explanation for the difference could be that we investigated subclinical thyroid disease, whereas Vestergaard et al. (2002) investigated overt and probably often complicated hypothyroidism.
A Swedish, longitudinal study reported a positive association between tobacco smoking and hypothyroidism (Nystrom et al. 1993) , but the increased incidence of hypothyroidism in that study was apparently found only among ex-smokers, and a control for age and other possible confounders was not reported. Further, the study was from an iodine-sufficient area. Other studies, also from iodinesufficient areas, have failed to detect an association between smoking and hypothyroidism (Bartalena et al. 1989 , Ericsson & Lindgarde 1991 , Prummel & Wiersinga 1993 . However, lower levels of TSH among smokers have generally been reported in most studies (Melander et al. 1981 , Eden et al. 1984 , Hegedus et al. 1985 , Ericsson & Lindgarde 1991 , Petersen et al. 1991 , Fisher et al. 1997 , and only one study found the reverse association (Sepkovic et al. 1984) . Though an iodine dependency of the association between smoking and hypothyroidism is imaginable, no clear picture of this is seen from the available literature.
A possible explanation for an association between tobacco smoking and subclinical hypothyroidism is a protective effect against the inhibitory effect of iodine on the thyroid (Laurberg et al. 1998) , a protective effect mediated by the competitive inhibition of iodine uptake by thiocyanate. This effect could be parallel to the observed lower incidences of hypothyroidism with decreasing iodine intake (Knudsen et al. 1999b) . It is possible that in our study we observed a lower occurrence of subclinical hypothyroidism among smokers as a direct effect of iodine depletion to the thyroid gland, whereas overt, severe hypothyroidism involves other mechanisms associated with smoking. This is supported by the absent involvement of thyroid autoimmunity in the association between smoking and subclinical hypothyroidism in our study, whereas most cases of overt, spontaneous hypothyroidism in Denmark involve thyroid autoimmunity (Knudsen et al. 1999b) . A negative association between thyroglobulin antibodies and tobacco smoking was found in this cohort, whereas the association between TPO antibodies and smoking was weaker ).
Thus, the transition from subclinical to overt hypothyroidism could be enhanced among smokers, and this could explain the conflicts with particularly the Danish results of Vestergaard et al. (2002) . The number of overt, undiagnosed cases of thyroid dysfunction was too small in our study to allow reliable analyses, and including known thyroid disease would have introduced the possibility of considerable selection bias.
We found no association between smoking and subclinical hyperthyroidism, although increased incidence of autoimmune hyperthyroidism has been found among smokers (Bartalena et al. 1989 , Prummel & Wiersinga 1993 , and an increased prevalence of thyroid autonomy could have been anticipated along with the increased prevalence of thyroid multinodularity. The increased levels of T4 and low TSH levels among smokers could still suggest a certain level of autonomous hormone secretion from the multiple nodules observed at ultrasonography.
In conclusion, a positive association was found between tobacco smoking and thyroid multinodularity and a negative association was found between smoking and subclinical hypothyroidism in areas with mild to moderate iodine deficiency. An iodine-blocking effect of thiocyanate on the thyroid is a possible explanation for these associations. Other mechanisms may be involved in the observed associations, as other mechanisms must be involved in the association between smoking and Graves' disease and ophthalmopathy.
